These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2233429)
1. Chemonucleolysis: a further look at a contentious issue. Taylor TK; Ghosh P; Melrose J Med J Aust; 1990 Nov; 153(10):575-8. PubMed ID: 2233429 [No Abstract] [Full Text] [Related]
2. The case for chemonucleolysis in discogenic sciatica. A review. Deutman R Acta Orthop Scand; 1992 Oct; 63(5):571-5. PubMed ID: 1306063 [No Abstract] [Full Text] [Related]
7. Residual chymopapain activity after chemonucleolysis in normal intervertebral discs in dogs. Malecha SE; Mayor GH J Bone Joint Surg Am; 1993 Jun; 75(6):950. PubMed ID: 8314835 [No Abstract] [Full Text] [Related]
8. Subarachnoid hemorrhage following chymopapain chemonucleolysis. Case report. Cusick JF; Ho KC; Schamberg JF J Neurosurg; 1987 May; 66(5):775-8. PubMed ID: 3572504 [TBL] [Abstract][Full Text] [Related]
9. In defense of chemonucleolysis. Shields CB Clin Neurosurg; 1986; 33():397-405. PubMed ID: 3791809 [No Abstract] [Full Text] [Related]
10. A comparative study of chemonucleolysis with recombinant human cathepsin L and chymopapain. A radiologic, histologic, and immunohistochemical assessment. Kubo S; Tajima N; Katunuma N; Fukuda K; Kuroki H Spine (Phila Pa 1976); 1999 Jan; 24(2):120-7. PubMed ID: 9926380 [TBL] [Abstract][Full Text] [Related]
12. [Chemonucleolysis: the last step in the conservative treatment of lumbar herniated disk]. Deryckere P; Deroulez A Acta Belg Med Phys; 1990; 13(2):39-44. PubMed ID: 2239011 [No Abstract] [Full Text] [Related]
13. [Detection of patients at risk of allergy to chymopapain before and after chemonucleolysis. Choice of preventive medication]. Castagnera L; Maurette P; Macouillard G; Lavignolle B Acta Orthop Belg; 1987; 53(2):213-20. PubMed ID: 3687407 [No Abstract] [Full Text] [Related]
14. Chemonucleolysis for sciatica. A critical review. Nachemson AL; Rydevik B Acta Orthop Scand; 1988 Feb; 59(1):56-62. PubMed ID: 3281406 [TBL] [Abstract][Full Text] [Related]
16. Chemonucleolysis. Personal history, trials, and tribulations. Smith L Clin Orthop Relat Res; 1993 Feb; (287):117-24. PubMed ID: 8448928 [TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for latent sensitization to chymopapain: predictive skin-prick tests in 700 candidates for chemonucleolysis. Moneret-Vautrin DA; Feldmann L; Kanny G; Baumann A; Roland J; Pere P Clin Exp Allergy; 1994 May; 24(5):471-6. PubMed ID: 8087659 [TBL] [Abstract][Full Text] [Related]
18. Intervertebral disc reconstitution after chemonucleolysis with chymopapain is dependent on dosage. Melrose J; Taylor TK; Ghosh P; Holbert C; Macpherson C; Bellenger CR Spine (Phila Pa 1976); 1996 Jan; 21(1):9-17. PubMed ID: 9122769 [TBL] [Abstract][Full Text] [Related]
19. Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. Grammer LC; Schafer M; Bernstein D; Bernstein IL; Cogen F; Dolovich J; Schatz M; Zeiger R; Shaughnessy JJ; Gutt L Clin Orthop Relat Res; 1988 Sep; (234):12-5. PubMed ID: 3409565 [TBL] [Abstract][Full Text] [Related]